Daniel Boren is listed as a director on 4 SEC Form D filings by 1 issuer between Jan 2014 and Dec 2014: EKSO BIONICS HOLDINGS, INC. (Richmond, CA — biotechnology — 2014; $50.8M reported sold to 200 investors).
What this means One deal on file with the SEC, filed Dec 2014. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Jack Peurach (4 shared filings), Marilyn Hamilton (4 shared filings), Max Scheder-Bieschin (4 shared filings), Nathan Harding (4 shared filings), Russ Angold (4 shared filings) and 3 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Daniel. Each name links to their own page.
The issuer belongs to the sponsor group Ekso Bionics (2 issuers, $5M reported sold, 2012–2021).
What this means A sponsor group is one team that sets up a new company for each deal. Ekso Bionics has 2 companies on file and $5M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 1 bankruptcy case matching the name listed in Key records below.
What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 4 public filings for Daniel Boren and found 2 differences: No amendment in the last 12 months on an offering that may still be open; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.